Clinical Trial Outcomes Influenced By Financial Ties Between Researchers And CompaniesNews
Research published in BMJ looked at a cross section of clinical trials from 2013 and describes a positive correlation between positive study outcomes and financial links between authors and drug companies.READ MORE
Cancerous cells often delete genes that suppress tumor formation, often these genes deletions extend into neighboring genes, this is known as "collateral lethality".READ MORE
A team of scientists at The Scripps Research Institute have developed a new method that enhances the discovery of new drugs and the study of proteins. The new method enables researchers to quickly find small molecules that bind to hundreds of thousands of proteins in their native cellular environment.READ MORE
Pall ForteBio will acquire the assets related to SensiQ's Pioneer product line.
Addition of Monolith NT from NanoTemper Technologies Ltd. enables Domainex to offer a unique protein production, characterisation, and fragment screening service.READ MORE